ADVERTISEMENT
News
Dermacyte - Merakris Therapeutics
06/12/2024
An 85-patient 2-part RCT will examine the efficacy of Dermacyte amniotic wound care matrix for the treatment of DFUs vs SoC with primary outcome of wound closure at 12 weeks. Not yet recruiting; the estimated study completion is May 2025. clinicaltrials.gov